"would that also mean that the number of patients will grow well beyond 2400, seeing that the BoM timeline is now into 2019?"

Koo, I don't know if the revised 2019 estimate is due to the observed event rate, changes to enrollment numbers, changes to total number of MACE events, another change to the BETonMACE protocol, something the FDA required, or a combination of these factors. It is quite ridiculous that the company has not divulged more information about these factors. We are long overdue for an update on these matters and I don't think I will be the only extremely frustrated one if they don't give an update prior to the December 12 AGM. It has been over 3 months (NR July 10) since they made a statement anticipating full enrollment this fall, and it has been just shy of 3 months (NR July 25) that they announced the approval pathway from the FDA regarding inclusion of US patients in BETonMACE.

BearDownAZ